Arteriosclerosis Obliterans

"Arteriosclerosis Obliterans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.

Descriptor ID

D001162

MeSH Number(s)

C14.907.137.126.114

Concept/Terms

Arteriosclerosis Obliterans

Below are MeSH descriptors whose meaning is more general than "Arteriosclerosis Obliterans".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Arterial Occlusive Diseases [C14.907.137]
Arteriosclerosis [C14.907.137.126]
Arteriosclerosis Obliterans [C14.907.137.126.114]

Below are MeSH descriptors whose meaning is related to "Arteriosclerosis Obliterans".

Below are MeSH descriptors whose meaning is more specific than "Arteriosclerosis Obliterans".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Arteriosclerosis Obliterans" by people in Harvard Catalyst Profiles by year, and whether "Arteriosclerosis Obliterans" was a major or minor topic of these publication.

Bar chart showing 2 publications over 2 distinct years, with a maximum of 1 publications in 1999 and 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2009	0	1	1

Below are the most recent publications written about "Arteriosclerosis Obliterans" by people in Profiles.

Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Circ Cardiovasc Interv. 2009 Jun; 2(3):245-54.

View in: PubMed
[A clinical trial of using antiplatelet therapy to prevent restenosis following peripheral artery angioplasty and stenting]. Zhonghua Yi Xue Za Zhi. 2008 Mar 25; 88(12):812-5.

View in: PubMed
[Therapeutic angiogenesis by autologous transplantation of bone-marrow cells in a patient with progressive limb ischemia due to arteriosclerosis obliterans: a case report]. J Cardiol. 2004 Apr; 43(4):179-83.

View in: PubMed
Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol. 1999 Dec; 155(6):1929-39.

View in: PubMed
[Percutaneous endoprosthesis of the iliac arteries. The first clinical trial of the use of the Iliac Wallstent endoprosthesis]. Kardiologiia. 1993; 33(8):78-80.

View in: PubMed
Antithrombotic therapy in peripheral vascular disease. Chest. 1986 Feb; 89(2 Suppl):75S-81S.

View in: PubMed
Surgery and the progression of the occlusive process in patients with peripheral vascular disease. Radiology. 1977 Aug; 124(2):343-8.

View in: PubMed
Atheromatous disease of the carotid artery. Correlation of angiographic, clinical, and surgical findings. J Neurosurg. 1974 Sep; 41(3):321-31.

View in: PubMed
Failure of vasodilator drugs in arteriosclerosis obliterans. Ann Intern Med. 1972 Jan; 76(1):35-9.

View in: PubMed
Detection of intravascular coagulation by a serial-dilution protamine sulfate test. Ann Intern Med. 1971 Dec; 75(6):895-902.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Surgery
N Engl J Med
Ann Intern Med
Surg Gynecol Obstet
Surg Forum
Radiology
Prensa Med Argent
J Cardiol
Del State Med J
Am J Pathol